Evidence map›Paper›PMID 26658224›Full record

ReviewDrug metabolism and disposition: the biological fate of chemicals2016

Design and Interpretation of Human Sulfotransferase 1A1 Assays.

Ting Wang, Ian Cook, Thomas S Leyh

Erratum issuedOpen access · bronzeAbstract readReview
In one paragraph

Review in Drug metabolism and disposition: the biological fate of chemicals, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Enzyme Kinetics of PAPS-Sulfotransferase.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  8. Article
  9. The Human UGT2B7 Nanodisc.Drug metabolism and disposition: the biological fate of chemicals · 2020
    Article
  10. Allosteres to regulate neurotransmitter sulfonation.The Journal of biological chemistry · 2019
    Article
  11. Article
  12. The NSAID allosteric site of human cytosolic sulfotransferases.The Journal of biological chemistry · 2017
    Article
  13. Tetrahydrobiopterin regulates monoamine neurotransmitter sulfonation.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  14. The structure of the catechin-binding site of human sulfotransferase 1A1.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ting WangDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.
Ian CookDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York.
Thomas S LeyhDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York tom.leyh@einstein.yu.edu.
Albert Einstein College of Medicine · US

Funding

Sulfotransferase Specificity and the Development of Sulfation Resistant CompoundsR01GM106158 · NIGMS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI LEYH, THOMAS S. · 2014 to 2016
$1.1M
NIGMS NIH HHS GM106158NIGMS NIH HHS R01 GM106158
6 · The paper itself

Abstract

The human sulfotransferases (SULTs) regulate the activities of hundreds, if not thousands, of small molecule metabolites via transfer of the sulfuryl-moiety (-SO3) from the nucleotide donor, 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the hydroxyls and amines of the recipients. Our understanding of the molecular basis of SULT catalysis has expanded considerably in recent years. The basic kinetic mechanism of these enzymes, previously thought to be ordered, has been redefined as random for SULT2A1, a representative member of the superfamily. An active-site cap whose structure and dynamics are highly responsive to nucleotides was discovered and shown to be critical in determining SULT selectivity, a topic of longstanding interest to the field. We now realize that a given SULT can operate in two specificity modes-broad and narrow-depending on the disposition of the cap. More recent work has revealed that the caps of the SULT1A1 are controlled by homotropic allosteric interactions between PAPS molecules bound at the dimer's active sites. These interactions cause the catalytic efficiency of SULT1A1 to vary in a substrate-dependent fashion by as much as two orders of magnitude over a range of PAPS concentrations that spans those found in human tissues. SULT catalysis is further complicated by the fact that these enzymes are frequently inhibited by their substrates. This review provides an overview of the mechanistic features of SULT1A1 that are important for the design and interpretation of SULT1A1 assays.

Indexed as

AnimalsArylsulfotransferaseCatalytic DomainEnzyme AssaysHumansProtein BindingProtein Structure, SecondarySubstrate SpecificityArylsulfotransferaseSULT1A1 protein, human

Identifiers

PMID26658224
PMCPMC4810762
OpenAlexW2290291347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.